Page 161 - CW E-Magazine (1-4-2025)

News from Abroad

LONGEVITY STUDIES
Sirio launches research institute to advance

anti-ageing science

Sirio Pharma, a China-based nutraceu-
tical contract development and manufac-
turing organisation (CDMO), announced
the launch of the ‘Sirio Institute for
Anti-Ageing (SIA)’ at the 2025 Boao
Health Food Science Conference and
Expo, held in Hainan, China recently.

The institute aims to advance anti-age-
ing science and accelerate the develop- Technology (SUSTech), will head the insti- manifestations, aiming to identify and
ment and commercialisation of innovative tute and assemble the Scientific Advisory the modulate fundamental mechanisms
nutraceutical products to promote healthy Board. The core research at the institute of ageing. We will conduct cutting-edge
longevity. “By leveraging cutting-edge will target the enhancement of cellular research into innovative bioactive ingre-
R&D capabilities, the SIA will provide health, the role of probiotics in reducing dients, synergistic formulations, delivery
customers with the knowledge, resources, the aging process, and the development and stability optimisation protocols, and
and support they need to bring ground- of novel nutraceutical formulations demonstrable consumer health benefits.”
breaking anti-ageing solutions to the addressing muscle loss and ovary func-
market,” the company said. tional decline during ageing. Dr. Youyou Zhao, Assistant Vice Presi-
dent of SIRIO, Global Head of Research
The SIA will explore the biological Commenting on the launch of the in- and Development, and Chief Scientist,
mechanisms of ageing and how they can stitute, Dr. Lyu said, “With global popu- added, “We are committed to creating
be modulated. Research at the institute lations rapidly greying, the demand for verifiable, traceable, and scientifically
will focus on four core areas: cellular scientifically validated nutraceuticals applicable evidence-based solutions for
health, probiotics and gut health, muscle that can delay or minimise the unwanted anti-ageing. By integrating cutting-edge
health, and reproductive system health. effects of ageing has reached unprecedented global anti-ageing research with valuable
The institute will be guided by a global levels. Yet many products on the market consumer insights and industrial applica-
Scientific Advisory Board composed of today frequently promote safety and effi- tions, we aim to enhance product value
experts in the field. cacy claims lacking robust scientific and and explore new market opportunities. So
clinical evidence. The SIA will pioneer that our brand partners can move ahead
Dr. Yu-Xuan Lyu, Research Assistant rigorous, evidence-based research and of the big trends of tomorrow, and most
Professor at the Institute of Advanced Bio- product development for our nutraceu- importantly deliver nutraceuticals that have
technology and the School of Medicine tical partners worldwide. Our approach best in class organoleptic properties com-
at the Southern University of Science and extends beyond merely delaying ageing bined with proven real-world efficacy.”
CARBOXYLIC ACID PORTFOLIO
OQ Chemicals to produce heptanoic acid at German
facility

OQ Chemicals (formerly Oxea), a strategy to strengthen its carboxylic positive decision for the future, enhanc-
manufacturer of oxo intermediates and acid portfolio. Commercial quantities ing our ability to meet increasing local
chemicals and part of Oman OQ group, are expected to be available by June demand. By leveraging our proprietary
is set to begin dedicated heptanoic acid 2025. Oxo production capabilities, we ensure
production in Oberhausen, Germany, in stability and the flexibility to adapt to
June 2025. This investment in expand- “This significant investment in our evolving market needs,” said Dr. Albrecht
ing its capacity is part of the company’s production site in Oberhausen marks a Schwerin, COO of OQ Chemicals.

Chemical Weekly April 1, 2025 161

Contents Index to Advertisers Index to Products Advertised